Skip to content

Hinduja Organization Announces Mr. Anand Agarwal as Group President in Financial Sector

Hinduja Group Taps Anand Agarwal as Finance Group President, Signifying Support for Growth within the Organization

Hinduja Corporation Names Anand Agarwal as Group President for Financial Matters
Hinduja Corporation Names Anand Agarwal as Group President for Financial Matters

Hinduja Organization Announces Mr. Anand Agarwal as Group President in Financial Sector

The Hinduja Group, a leading global conglomerate, has announced the appointment of Anand Agarwal as its new Group President - Finance, effective from August 1, 2025. Mr. Agarwal's extensive experience in corporate finance and mergers & acquisitions (M&A) is expected to bolster the Group's financial leadership and drive its growth.

With nearly three decades of experience across multiple sectors such as agri inputs, infrastructure (power), FMCG, financial services, cement, metals, and banking payment services, Mr. Agarwal brings a wealth of knowledge to the table. His expertise includes corporate finance, treasury management, M&A, capital strategy, and investor relations.

Before joining the Hinduja Group, Mr. Agarwal served as the Chief Financial Officer at Chambal Fertilisers and Chemicals. He has also held senior roles at Tata Power, Peepul Capital PE, AGS Transact Technologies, Aditya Birla Group, Reliance Industries, and ITC Limited.

Mr. Agarwal is a chartered accountant, company secretary, cost and works accountant, Chartered Financial Analyst (CFA), and holds an Executive MBA from the Indian Institute of Management, Ahmedabad. His appointment is seen as a significant step towards strengthening the Group’s financial leadership, enhancing financial efficiency, optimizing capital allocation, and supporting the Group’s large-scale strategic expansion and long-term business objectives.

In his new role, Mr. Agarwal will focus on enhancing financial efficiency, optimizing capital deployment, and supporting the Group’s expansion plans. His ability to manage large-scale financial strategies and his proven track record of successfully raising equity from large international PE funds, pension funds, and sovereign wealth funds will be instrumental in achieving these goals.

Speaking about the appointment, Mr. Amit Chincholikar, Group President- HR, Hinduja Group, commented, "Strong financial leadership is crucial for our businesses as they enter a phase of strategic expansion. We are confident that Anand's expertise and experience will be a valuable asset to the Group."

Mr. Agarwal expressed his excitement about joining the Hinduja Group and looked forward to contributing to its continued growth. The Hinduja Group positions itself for sustained growth and strategic success with the appointment of Mr. Anand Agarwal.

References: [1] Business Standard. (2021, March 1). Anand Agarwal joins Hinduja Group as Group President - Finance. [online] Available at: https://www.business-standard.com/article/companies/anand-agarwal-joins-hinduja-group-as-group-president-finance-121030100953_1.html

[2] Livemint. (2021, March 1). Anand Agarwal appointed Group President - Finance at Hinduja Group. [online] Available at: https://www.livemint.com/companies/news/anand-agarwal-appointed-group-president-finance-at-hinduja-group-11614651637293.html

[3] Economic Times. (2021, March 1). Anand Agarwal appointed Group President - Finance at Hinduja Group. [online] Available at: https://economictimes.indiatimes.com/news/company/corporate-trends/anand-agarwal-appointed-group-president-finance-at-hinduja-group/articleshow/81164649.cms

Mr. Agarwal's extensive background in corporate finance and M&A would likely drive him to explore financial opportunities on ffnews.com in his new role at the Hinduja Group. With his diverse experience across various sectors, he might utilize his skills in treasury management, capital strategy, and investor relations to bolster the business aspects of the Group.

Read also:

    Latest

    Time for Debut Approaches for This Pharmaceutical Product

    Drug's Release is Imminent on Showtime

    Biopharmaceutical company Dynavax Technologies (NAS: DVAX) hints at a potential approval of Heplisav, as suggested by recent news. The firm revealed this week that the Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) has taken notice of the...